Ekkehard Schütz

Hoofd Techniek/Wetenschap/O&O bij ONCOCYTE CORPORATION

Vermogen: - $ op 30-04-2024

Health Technology

Consumer Services

Actieve functies van Ekkehard Schütz

Bedrijven	Functie	Begin	Einde
ONCOCYTE CORPORATION	Hoofd Techniek/Wetenschap/O&O	01-04-2021	-
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Algemeen Directeur	-	-
	Hoofd Techniek/Wetenschap/O&O	-	-
Chronix Biomedical GmbH	Corporate Officer/Principal	01-04-2011	-

University of Gottingen

Doctorate Degree

Internationaal

Operationeel

Sectoraal

Health Technology	3
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
ONCOCYTE CORPORATION	Health Technology

Bedrijven in privébezit	2
Chronix Biomedical, Inc. Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA.	Health Technology
Chronix Biomedical GmbH

Bedrijven in privébezit

Health Technology

Chronix Biomedical GmbH